Weight-loss injections, particularly semaglutide, are gaining attention due to their effectiveness in managing obesity. Semaglutide mimics a hormone that reduces appetite by tricking the brain into feeling full. Many individuals experience a transformative relationship with food, as demonstrated by trial participant Jan, who noted a significant change in her cravings and eating habits. While participants in trials lost an average of 15% of their body weight when combined with healthy lifestyle choices, concerns arise regarding the long-term implications of relying on such medication instead of addressing obesity's root causes.
Semaglutide mimics a hormone that is released when we eat, tricking the brain into thinking we are full and dialing down appetite.
On average, people who were obese lost about 15% of their body weight when taking semaglutide alongside healthy lifestyle advice in a trial.
Excess weight affects health and leads to stigma, and the mantra of 'diet and exercise' has simply failed for most people.
Jan’s transformational relationship with food was either down to the drug or she felt, 'I've been abducted by aliens'.
Collection
[
|
...
]